Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulants

References

• Chen A, Stecker E, Warden AB. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13):e017559. doi: 10.1161/JAHA.120.017559
   PubMed Web of Science ®Google Scholar
• Ingrasciotta Y, Crisafulli S, Pizzimenti V, et al. Pharmacokinetics of new oral anticoagulants: implications for use in routine care. Expert Opin Drug Metab Toxicol. 2018;14(10):1057–1069. doi: 10.1080/17425255.2018.1530213
   PubMed Web of Science ®Google Scholar
• De Caterina R, Kelly P, Monteiro P, et al. Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe). BMC Cardiovasc Disord. 2019 Jul 12;19(1):165. doi: 10.1186/s12872-019-1144-x
   PubMedGoogle Scholar
• Ioannou M, Leonidou E, Chaziri I, et al. Direct oral anticoagulants: navigating through clinical challenges. Cardiovasc Drugs Ther. 2023 Aug 8. doi: 10.1007/s10557-023-07499-0
   PubMed Web of Science ®Google Scholar
• Caturano A, Brunelli V, Spiezia S, et al. An update on betrixaban, the challenging anticoagulant agent for extended venous thromboembolism prophylaxis. J Cardiovasc Pharmacol. 2023 Oct 27. doi: 10.1097/FJC.0000000000001504
   Google Scholar
• Wiggins BS, Dixon DL, Neyens RR, et al. Select drug-drug interactions with direct oral anticoagulants: JACC review topic of the Week. J Am Coll Cardiol. 2020;75(11):1341–1350. doi: 10.1016/j.jacc.2019.12.068
   PubMed Web of Science ®Google Scholar
• Grymonprez M, Carnoy L, Capiau A, et al. Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study. Eur Heart J Cardiovasc Pharmacother. 2023;9(8):722–730. doi: 10.1093/ehjcvp/pvad070
   PubMed Web of Science ®Google Scholar
• Trifirò G, Corrao S, Alacqua M, et al. Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources. Br J Clin Pharmacol. 2006;62(5):582–590. doi: 10.1111/j.1365-2125.2006.02687.x
   PubMed Web of Science ®Google Scholar
• Monteith S, Glenn T. Comparison of potential psychiatric drug interactions in six drug interaction database programs: a replication study after 2 years of updates. Hum Psychopharmacol. 2021;36(6):e2802. doi: 10.1002/hup.2802
   PubMed Web of Science ®Google Scholar
• Abarca J, Malone DC, Armstrong EP, et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc (2003). 2004;44(2):136–141. doi: 10.1331/154434504773062582
   PubMedGoogle Scholar
• INTERCheck Web. [cited 2023 Nov 23]. Available from: https://intercheckweb.marionegri.it/
   Google Scholar
• Micromedex. [cited 2023 Nov 23]. Available from: https://www.ibm.com/it-it/watson-health/about/micromedex
   Google Scholar
• Lexicomp. Interactions. [cited 2023 Nov 23]. Available from: https://www.wolterskluwer.com/en/solutions/lexicomp/resources/lexicomp-user-academy/drug-interactions-analysis
   Google Scholar
• Epocrates. Interaction check. [cited 2023 Nov 23]. Available from: https://online.epocrates.com/interaction-check
   Google Scholar
• Drugs.com. Drug interactions checker. [cited 2023 Nov 23]. Available from: https://www.drugs.com/drug_interactions.html
   Google Scholar
• Morte-Romea E, Luque-Gómez P, Arenere-Mendoza M, et al. Performance assessment of software to detect and assist prescribers with antimicrobial drug interactions: are all of them created equal? Antibiotics. 2020 Jan 4;9(1):19. doi: 10.3390/antibiotics9010019
   Google Scholar
• Kheshti R, Aalipour M, Namazi S. A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract. 2016;5(4):257–263. doi: 10.4103/2279-042X.192461
   PubMed Web of Science ®Google Scholar
• Apidi NA, Murugiah MK, Muthuveloo R, et al. Mobile medical applications for dosage recommendation, drug adverse reaction, and drug interaction: review and comparison. Ther Innov Regul Sci. 2017;51(4):480–485. doi: 10.1177/2168479017696266
   PubMed Web of Science ®Google Scholar
• Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018 Sep 3;9(9):CD008165. doi: 10.1002/14651858.CD008165.pub4
   PubMed Web of Science ®Google Scholar
• FDA. Frequently asked questions. [cited 2023 Nov 23]. Available from: https://www.fda.gov/drugs/frequently-asked-questions-popular-topics/how-can-i-stay-better-informed-about-drugs-there-reliable-website-fda-recommends
   Google Scholar
• ATC/DDD index 2024. WHO collaborating centre for drug statistics methodology. 2023. [cited 2023 Dec 4]. Available from: https://www.whocc.no/atc_ddd_index/
   Google Scholar
• Wongpakaran N, Wongpakaran T, Wedding D, et al. A comparison of Cohen’s kappa and Gwet’s AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples. BMC Med Res Methodol. 2013 Apr 29;13(1):61. doi: 10.1186/1471-2288-13-61
   PubMed Web of Science ®Google Scholar
• Gisev N, Bell JS, Chen TF. Interrater agreement and interrater reliability: key concepts, approaches, and applications. Res Social Adm Pharm. 2013;9(3):330–338. doi: 10.1016/j.sapharm.2012.04.004
   PubMed Web of Science ®Google Scholar
• Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76(5):378–382. doi: 10.1037/h0031619
   Google Scholar
• Roblek T, Vaupotic T, Mrhar A, et al. Drug-drug interaction software in clinical practice: a systematic review. Eur J Clin Pharmacol. 2015;71(2):131–142. doi: 10.1007/s00228-014-1786-7
   PubMed Web of Science ®Google Scholar
• Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol. 2007;63(6):709–714. doi: 10.1111/j.1365-2125.2006.02809.x
   PubMed Web of Science ®Google Scholar
• Kontsioti E, Maskell S, Bensalem A, et al. Similarity and consistency assessment of three major online drug-drug interaction resources. Br J Clin Pharmacol. 2022;88(9):4067–4079. doi: 10.1111/bcp.15341
   PubMed Web of Science ®Google Scholar
• Shariff A, Belagodu Sridhar S, Abdullah Basha NF, et al. Assessing consistency of drug-drug interaction-related information across various drug information resources. Cureus. 2021 Mar 8;13(3):e13766.
   PubMed Web of Science ®Google Scholar
• Roca B, Roca M. Assessment of drug interactions with online electronic checkers in multi-pathological patients. Pharmacology. 2022;107(1–2):111–115. doi: 10.1159/000518439
   PubMed Web of Science ®Google Scholar
• Günay A, Demirpolat E, Ünal A, et al. A comparison of four drug-drug interaction databases for patients undergoing haematopoietic stem cell transplantation. J Clin Pharm Ther. 2022;47(10):1711–1719. doi: 10.1111/jcpt.13728
   PubMed Web of Science ®Google Scholar
• Glassman PA, Simon B, Belperio P, et al. Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med care. 2002;40(12):1161–1171. doi: 10.1097/00005650-200212000-00004
   PubMed Web of Science ®Google Scholar
• Page N, Baysari MT, Westbrook JI. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety. Int J Med Inform. 2017;105:22–30. doi: 10.1016/j.ijmedinf.2017.05.011
   PubMed Web of Science ®Google Scholar
• Suriyapakorn B, Chairat P, Boonyoprakarn S, et al. Comparison of potential drug-drug interactions with metabolic syndrome medications detected by two databases. PLoS One. 2019 Nov 14;14(11):e0225239. doi: 10.1371/journal.pone.0225239
   PubMed Web of Science ®Google Scholar
• McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276–282.
   PubMed Web of Science ®Google Scholar
• Popplewell M, Reizes J, Zaslawski C. Appropriate statistics for determining chance-removed interpractitioner agreement. J Altern Complement Med. 2019;25(11):1115–1120. doi: 10.1089/acm.2017.0297
   PubMed Web of Science ®Google Scholar